HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[A case of liver metastasis of primary duodenal cancer effectively treated with docetaxel therapy].

Abstract
A 75-year-old man who complained of upper abdominal discomfort was diagnosed with primary duodenal cancer. The patient was treated with a pancreaticoduodenectomy, ascending colectomy and postoperative chemotherapy of S-1 and irinotecan[IRIS; S-1, 80mg/m2(days 1-14); irinotecan, 100 mg/m2(days 1 and 15, every 4 weeks)]. However, after 4 IRIS cycles, computed tomography revealed a liver metastasis and massive ascites. The patient received second-line chemotherapy of tri-weekly docetaxel[60mg/m2,(day 1, every 3 weeks)]. After 2 cycles of docetaxel therapy, the liver tumor and ascites became undetectable. The patient was doing well 13 months after the operation.
AuthorsAkiho Okada, Masahiro Hata, Yoshinori Taeda, Ryo Ushijima
JournalGan to kagaku ryoho. Cancer & chemotherapy (Gan To Kagaku Ryoho) Vol. 40 Issue 11 Pg. 1541-4 (Nov 2013) ISSN: 0385-0684 [Print] Japan
PMID24231711 (Publication Type: Case Reports, Journal Article, Review)
Chemical References
  • Antineoplastic Agents
  • Taxoids
  • Docetaxel
Topics
  • Aged
  • Antineoplastic Agents (therapeutic use)
  • Ascites (etiology)
  • Docetaxel
  • Duodenal Neoplasms (drug therapy, pathology, surgery)
  • Humans
  • Liver Neoplasms (drug therapy, secondary)
  • Male
  • Taxoids (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: